Trial Profile
Risperidone depot (microspheres) in the treatment of subjects with schizophrenia or schizoaffective disorder
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Oct 2007
Price :
$35
*
At a glance
- Drugs Risperidone (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Adverse reactions; Registrational
- 05 Nov 2005 New trial record.